British pharma giant GSK to acquire US drug developer IDRx in $1.15 billion deal




The biopharmaceutical company’s drug in development is designed to treat gastrointestinal stromal tumors (GIST). Read More



Source link

  • Related Posts

    China’s UBTech Robotics rallies Foxconn partnership By Investing.com

    Investing.com– Features of Ubtech Robotics Corp Ltd (HK: ) rose sharply on Wednesday after the company and electronics giant yes yes Precision Industry (TW :)), also known as Foxconn (SS…

    Why FuboTV Shares Fell Today

    Shares of FuboTV (NYSE: FUBO) they were pulling back today after a surge last week that reached an agreement to merge Disney‘s (NYSE: DIS) Hulu + Live TV. There was…

    Leave a Reply

    Your email address will not be published. Required fields are marked *